SCYNEXIS, Inc. (SCYX)
4.98
-0.17
(-3.30%)
USD |
NASDAQ |
Sep 09, 11:40
SCYNEXIS Enterprise Value : -0.9776M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | -0.9776M |
| September 04, 2026 | 0.5149M |
| September 03, 2026 | 0.9626M |
| September 02, 2026 | -0.2811M |
| September 01, 2026 | -0.7786M |
| August 31, 2026 | -0.1816M |
| August 28, 2026 | 1.410M |
| August 27, 2026 | 2.704M |
| August 26, 2026 | 4.196M |
| August 25, 2026 | -0.5796M |
| August 24, 2026 | 0.1169M |
| August 21, 2026 | -1.475M |
| August 20, 2026 | -0.2811M |
| August 19, 2026 | -0.9776M |
| August 18, 2026 | -1.077M |
| August 17, 2026 | -1.574M |
| August 14, 2026 | -0.6791M |
| August 13, 2026 | -1.276M |
| August 12, 2026 | -4.360M |
| August 11, 2026 | -4.112M |
| August 10, 2026 | -0.9278M |
| August 07, 2026 | -0.0821M |
| August 06, 2026 | -0.4801M |
| August 05, 2026 | -0.8781M |
| August 04, 2026 | 1.510M |
| Date | Value |
|---|---|
| August 03, 2026 | -1.774M |
| July 31, 2026 | -4.062M |
| July 30, 2026 | -15.11M |
| July 29, 2026 | -14.71M |
| July 28, 2026 | -16.10M |
| July 27, 2026 | -16.70M |
| July 24, 2026 | -15.11M |
| July 23, 2026 | -12.82M |
| July 22, 2026 | -12.87M |
| July 21, 2026 | -11.92M |
| July 20, 2026 | -13.46M |
| July 17, 2026 | -9.733M |
| July 16, 2026 | -7.644M |
| July 15, 2026 | -4.161M |
| July 14, 2026 | -3.166M |
| July 13, 2026 | -7.644M |
| July 10, 2026 | -8.639M |
| July 09, 2026 | -6.798M |
| July 08, 2026 | -5.654M |
| July 07, 2026 | -6.350M |
| July 06, 2026 | -5.156M |
| July 02, 2026 | -8.141M |
| July 01, 2026 | -10.13M |
| June 30, 2026 | -11.72M |
| June 29, 2026 | -27.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.848B |
| Corcept Therapeutics, Inc. | 12.00B |
| Veru, Inc. | 20.88M |
| Johnson & Johnson | 676.38B |
| Eli Lilly & Co. | 1.104T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.397M |
| Revenue (Quarterly) | 0.235M |
| Total Expenses (Quarterly) | -7.162M |
| EPS Diluted (Quarterly) | 0.6256 |
| Earnings Yield | -37.02% |
| Normalized Earnings Yield | -44.22 |